Buy Cipla, Aurobindo Pharma: CA Rudramurthy

CA Rudramurthy of Vachana Investments told CNBC-TV18, "If I look specifically pharma as a sector and even IT, because of the rupee falling down along with the Chinese Yuan, I see definitely IT and pharma to slightly outperform the market. However, as the overall market is very weak, I just see a slight outperformance from these two sectors but I don’t see a spectacular rise from current level.""One can look at stocks like Cipla and Aurobindo Pharma which looks very interesting both for investment as well as for short-term trading. Aurobindo Pharma has been doing pretty well and even Cipla at levels of around Rs 650-670 makes a sensible buy along with Aurobindo Pharma. However, midcap pharma also looks good for an investment of two-three year timeframe," he said.